Published in J Neurotrauma on January 01, 2002
Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Ther (2008) 0.89
Enhanced neurite outgrowth of human model (NT2) neurons by small-molecule inhibitors of Rho/ROCK signaling. PLoS One (2015) 0.83
Transgene-mediated GDNF expression enhances synaptic connectivity and GABA transmission to improve functional outcome after spinal cord contusion. J Neurochem (2010) 0.81
Neuroprotection and axonal regeneration after lumbar ventral root avulsion by re-implantation and mesenchymal stem cells transplant combined therapy. Neurotherapeutics (2013) 0.81
Valproic acid protects neurons and promotes neuronal regeneration after brachial plexus avulsion. Neural Regen Res (2013) 0.75
Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum (2003) 3.39
The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem (2004) 1.75
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Ann Neurol (2002) 1.74
An HSV vector system for selection of ligand-gated ion channel modulators. Nat Methods (2007) 1.57
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther (2004) 1.56
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol (2005) 1.47
Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol (2006) 1.43
Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol (2002) 1.40
HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain. Mol Pain (2006) 1.32
Gene therapy for pain: results of a phase I clinical trial. Ann Neurol (2011) 1.31
American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther (2003) 1.29
Progress in gene therapy for neurological disorders. Nat Rev Neurol (2013) 1.22
Herpes vector-mediated gene transfer in treatment of diseases of the nervous system. Annu Rev Microbiol (2004) 1.21
Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther (2008) 1.17
Translating the genomics revolution: the need for an international gene therapy consortium for monogenic diseases. Mol Ther (2013) 1.16
IL-10 promotes neuronal survival following spinal cord injury. Exp Neurol (2009) 1.16
Glial TNFα in the spinal cord regulates neuropathic pain induced by HIV gp120 application in rats. Mol Pain (2011) 1.15
Herpes simplex-mediated gene transfer of nerve growth factor protects against peripheral neuropathy in streptozotocin-induced diabetes in the mouse. Diabetes (2002) 1.14
Interleukin-10 provides direct trophic support to neurons. J Neurochem (2009) 1.14
Engineering an endomorphin-2 gene for use in neuropathic pain therapy. Pain (2007) 1.13
Continuous delta-opioid receptor activation reduces neuronal voltage-gated sodium channel (NaV1.7) levels through activation of protein kinase C in painful diabetic neuropathy. J Neurosci (2008) 1.13
Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons. Eur J Neurosci (2008) 1.12
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol Ther (2003) 1.07
Effects of transgene-mediated endomorphin-2 in inflammatory pain. Eur J Pain (2008) 1.06
Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain (2004) 1.04
Applications of gene therapy to the treatment of chronic pain. Curr Gene Ther (2008) 1.03
The relationship of herpes simplex virus latency associated transcript expression to genome copy number: a quantitative study using laser capture microdissection. J Neurovirol (2002) 1.01
Soluble Nogo receptor down-regulates expression of neuronal Nogo-A to enhance axonal regeneration. J Biol Chem (2009) 1.00
A novel cell-cell signaling by microglial transmembrane TNFα with implications for neuropathic pain. Pain (2010) 0.97
Neuroprotective effect of herpes simplex virus-mediated gene transfer of erythropoietin in hyperglycemic dorsal root ganglion neurons. Brain (2009) 0.97
Engineering HSV-1 vectors for gene therapy. Methods Mol Biol (2014) 0.96
Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. Mol Ther (2005) 0.96
Release of GABA from sensory neurons transduced with a GAD67-expressing vector occurs by non-vesicular mechanisms. Brain Res (2006) 0.94
Vector-mediated release of GABA attenuates pain-related behaviors and reduces Na(V)1.7 in DRG neurons. Eur J Pain (2011) 0.93
Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery. Mol Ther (2003) 0.93
Neuronal Nogo-A regulates glutamate receptor subunit expression in hippocampal neurons. J Neurochem (2011) 0.93
Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha. Neurosci Lett (2008) 0.93
Volatile anesthetics affect nutrient availability in yeast. Genetics (2002) 0.92
Gene delivery using herpes simplex virus vectors. DNA Cell Biol (2002) 0.92
Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo. Hum Gene Ther (2006) 0.91
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Mol Ther (2004) 0.91
Development of replication-defective herpes simplex virus vectors. Methods Mol Med (2002) 0.90
Gene therapy: novel treatments for polyneuropathy and chronic pain. Curr Neurol Neurosci Rep (2004) 0.90
Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin. Mol Ther (2010) 0.90
Inhibition of translation initiation by volatile anesthetics involves nutrient-sensitive GCN-independent and -dependent processes in yeast. Mol Biol Cell (2005) 0.89
Improvement in erectile dysfunction after neurotrophic factor gene therapy in diabetic rats. J Urol (2005) 0.89
Protective effect of HSV-mediated gene transfer of nerve growth factor in pyridoxine neuropathy demonstrates functional activity of trkA receptors in large sensory neurons of adult animals. Eur J Neurosci (2003) 0.89